The present study mainly determined the serum levels of the host lipid regulators ANGPTL-3 and ANGPTL-4 in HCV patients throughout the natural history of hepatitis C, from acute infection to HCC. This evidence concerns the gene ANGPTL4 and hepatocellular carcinoma.